DeepCure vs Synta Pharmaceuticals
DeepCure
Reimagining small molecule therapies for immune diseases
28 employees · est. 2018 · Boston, United States
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditions, including cancer and chronic inflammatory diseases
est. 2000
Synta Pharmaceuticals is the older company (2018 vs 2000).
Side-by-Side Comparison
| Metric | DeepCure | Synta Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2000 older |
| Headquarters | ||
| Headquarters | Boston, United States | Not tracked yet |
| Employees | ||
| Employees | 28 | Not tracked yet |
| Industry | ||
| Industry | AI, Biotechnology, Machine Learning | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $64.60M | $217.35M |
| Funding Rounds | ||
| Funding Rounds | 5 | 8 |
| Services | ||
| Services | Development of small molecule therapies, Research and development of STAT6 inhibitors, Collaboration with academic and research institutions | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech firms, Healthcare providers, Medical researchers, Patients with immune diseases | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Small Molecule TherapiesImmune DiseasesInflammatory DiseasesAI-Driven Drug DiscoveryNovel MoleculesDrug Discovery Platform +9 | Biopharmaceutical CompanySmall Molecule DrugsCancer TreatmentChronic Inflammatory DiseasesDrug DiscoveryClinical Development +7 |
| Website | ||
| Website | deepcure.com | syntapharma.com |
About DeepCure
DeepCure, founded in 2018 and headquartered in the United States, is innovating the landscape of small molecule therapies specifically targeting immune and inflammatory diseases. The company's slogan, "Reimagining small molecule therapies for immune diseases," encapsulates its mission to introduce g...
About Synta Pharmaceuticals
Synta Pharmaceuticals is a biopharmaceutical company founded in 2000, with a focus on discovering, developing, and commercializing small molecule drugs to improve the lives of patients with severe medical conditions such as cancer and chronic inflammatory diseases. The company has a global partnersh...
Also comparing in this category
Comparing more than these two?
Get DeepCure, Synta Pharmaceuticals and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does DeepCure compare?
A PDF of DeepCure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare DeepCure with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at DeepCure on 15 Jun 2026, and Synta Pharmaceuticals on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
